These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 9667646)
1. Selective activation of oncogenic Ha-ras-induced apoptosis in NIH/3T3 cells. Liu HS; Chen CY; Lee CH; Chou YI Br J Cancer; 1998 Jun; 77(11):1777-86. PubMed ID: 9667646 [TBL] [Abstract][Full Text] [Related]
2. Dominant-negative Rac1 suppresses Ras-induced apoptosis possibly through activation of NFkappaB in Ha-ras oncogene-transformed NIH/3T3 cells. Chou CK; Liang KH; Tzeng CC; Huang GC; Chuang JI; Chang TY; Liu HS Life Sci; 2006 Mar; 78(16):1823-9. PubMed ID: 16274703 [TBL] [Abstract][Full Text] [Related]
3. Selective activation of Ha-ras(val12) oncogene increases susceptibilityof NIH/3T3 cells to TNF-alpha. Chang MY; Won SJ; Yang BC; Jan MS; Liu HS Exp Cell Res; 1999 May; 248(2):589-98. PubMed ID: 10222151 [TBL] [Abstract][Full Text] [Related]
4. Ha-rasVal12 oncogene increases susceptibility of NIH/3T3 cells to lovastatin. Chang MY; Jan MS; Won SJ; Liu HS Biochem Biophys Res Commun; 1998 Jul; 248(1):62-8. PubMed ID: 9675086 [TBL] [Abstract][Full Text] [Related]
5. Glutathione depletion-induced apoptosis of Ha-ras-transformed NIH3T3 cells can be prevented by melatonin. Chuang JI; Chang TY; Liu HS Oncogene; 2003 Mar; 22(9):1349-57. PubMed ID: 12618760 [TBL] [Abstract][Full Text] [Related]
6. Ha-ras overexpression mediated cell apoptosis in the presence of 5-fluorouracil. Tseng YS; Tzeng CC; Chiu AW; Lin CH; Won SJ; Wu IC; Liu HS Exp Cell Res; 2003 Aug; 288(2):403-14. PubMed ID: 12915131 [TBL] [Abstract][Full Text] [Related]
7. Identifying the factors and signal pathways necessary for anchorage-independent growth of Ha-ras oncogene-transformed NIH/3T3 cells. Chang TY; Tsai WJ; Chou CK; Chow NH; Leu TH; Liu HS Life Sci; 2003 Jul; 73(10):1265-74. PubMed ID: 12850242 [TBL] [Abstract][Full Text] [Related]
8. A ribozyme specifically suppresses transformation and tumorigenicity of Ha-ras-oncogene-transformed NIH/3T3 cell lines. Chang MY; Won SJ; Liu HS J Cancer Res Clin Oncol; 1997; 123(2):91-9. PubMed ID: 9030247 [TBL] [Abstract][Full Text] [Related]
9. Increased methotrexate resistance and dhfr gene amplification as a consequence of induced Ha-ras expression in NIH 3T3 cells. Wani MA; Xu X; Stambrook PJ Cancer Res; 1994 May; 54(9):2504-8. PubMed ID: 8162600 [TBL] [Abstract][Full Text] [Related]
10. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function. Kuo ML; Chou YW; Chau YP; Huang TS Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217 [TBL] [Abstract][Full Text] [Related]
11. The role of autophagy in cytotoxicity induced by new oncogenic B-Raf inhibitor UI-152 in v-Ha-ras transformed fibroblasts. Ahn JH; Ahn SK; Lee M Biochem Biophys Res Commun; 2012 Jan; 417(2):857-63. PubMed ID: 22206679 [TBL] [Abstract][Full Text] [Related]
12. The enhancement of Raf-1 kinase activity by knockdown of Spry2 is associated with high sensitivity to paclitaxel in v-Ha-ras-transformed NIH 3T3 fibroblasts. Ahn JH; Eum KH; Lee M Mol Cell Biochem; 2009 Dec; 332(1-2):189-97. PubMed ID: 19588231 [TBL] [Abstract][Full Text] [Related]
13. Opposite effects of Ha-Ras and Ki-Ras on radiation-induced apoptosis via differential activation of PI3K/Akt and Rac/p38 mitogen-activated protein kinase signaling pathways. Choi JA; Park MT; Kang CM; Um HD; Bae S; Lee KH; Kim TH; Kim JH; Cho CK; Lee YS; Chung HY; Lee SJ Oncogene; 2004 Jan; 23(1):9-20. PubMed ID: 14712206 [TBL] [Abstract][Full Text] [Related]
14. The inducible lactose operator-repressor system is functional in the whole animal. Wu JD; Hsueh HC; Huang WT; Liu HS; Leung HW; Ho YR; Lin MT; Lai MD DNA Cell Biol; 1997 Jan; 16(1):17-22. PubMed ID: 9022041 [TBL] [Abstract][Full Text] [Related]
15. The human Ha-ras oncogene induces genomic instability in murine fibroblasts within one cell cycle. Denko NC; Giaccia AJ; Stringer JR; Stambrook PJ Proc Natl Acad Sci U S A; 1994 May; 91(11):5124-8. PubMed ID: 8197195 [TBL] [Abstract][Full Text] [Related]
16. Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway. Sheng H; Williams CS; Shao J; Liang P; DuBois RN; Beauchamp RD J Biol Chem; 1998 Aug; 273(34):22120-7. PubMed ID: 9705357 [TBL] [Abstract][Full Text] [Related]
17. Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation. Heinicke T; Radziwill G; Nawrath M; Rommel C; Pavlovic J; Moelling K Cancer Gene Ther; 2000 May; 7(5):697-706. PubMed ID: 10830717 [TBL] [Abstract][Full Text] [Related]
18. Mitotic and post mitotic consequences of genomic instability induced by oncogenic Ha-ras. Denko N; Stringer J; Wani M; Stambrook P Somat Cell Mol Genet; 1995 Jul; 21(4):241-53. PubMed ID: 8525430 [TBL] [Abstract][Full Text] [Related]
19. Crosstalk between autophagy and apoptosis in the regulation of paclitaxel-induced cell death in v-Ha-ras-transformed fibroblasts. Eum KH; Lee M Mol Cell Biochem; 2011 Feb; 348(1-2):61-8. PubMed ID: 21069434 [TBL] [Abstract][Full Text] [Related]
20. The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression. Barradas M; Monjas A; Diaz-Meco MT; Serrano M; Moscat J EMBO J; 1999 Nov; 18(22):6362-9. PubMed ID: 10562548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]